IceCure Medical Receives Approval From China's National Medical Products Administration For Its ProSense System, Associated Cryoprobes
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to
IceCure Medical got permission from China to sell its freezing tool that destroys tumors. This is good news for the company because China is a huge market, so watch whether this leads to real sales.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.